Immunological features of Pneumocystis carinii infection in humans

Clinical and Diagnostic Laboratory Immunology

Volumn 6, Issue 2, 1999, Pages 149-155

  Walzer, Peter D ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOTHERAPY; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PNEUMOCYSTOSIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033017023     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.6.2.149-155.1999     Document Type: Short Survey

References (139)

1. Agostini, C., F. Adami, L. W. Poulter, D. Israel-Biet, M. Freitas e Costa, A. Cipriani, R. Sancetta, M. C. Lipman, K. Juvin, A. D. Teles-Araujo, P. Cadrobbi, G. Masarotto, and G. Semenzato. 1997. Role of bronchoalveolar lavage in predicting survival of patients with human immunodeficiency virus infection. Am. J. Respir. Crit. Care Med. 156:1501-1507.
2. Angelici, E., C. Contini, R. Romani, O. Epifano, P. Serra, and R. Canipari. 1996. Production of plasminogen activator and plasminogen activator inhibitors by alveolar macrophages in control subjects and AIDS patients. AIDS 10:283-290.
3. Angus, C. W., A. Tu, P. Vogel, M. Qin, and J. A. Kovacs. 1996. Expression of variants of the major surface glycoprotein of Pneumocystis carinii. J. Exp. Med. 183:1229-1234.
4. Armstrong, M. Y. K., and M. T. Cushion. 1994. Animal models, p. 181-222. In P. D. Walzer (ed.), Pneumocystis carinii pneumonia. Marcel Dekker, New York, N.Y.
5. Barltett, M. S., W. C. Angus, M. M. Shaw, P. J. Durant, C. H. Lee, J. M. Pascale, and J. W. Smith. 1998. Antibody to Pneumocystis carinii protects rats and mice from developing pneumonia. Clin. Diagn. Lab. Immun. 5:74-77.
6. Baughman, R. P. 1994. Current methods of diagnosis, p. 381-401. In P. D. Walzer (ed.), Pneumocystis carinii pneumonia. Marcel Dekker, New York, N.Y.
7. Beck, J. M., H. D. Liggitt, E. N. Brunette, H. J. Fuchs, J. E. Shellito, and R. J. Debbs. 1991. Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon. Infect. Immun. 59:3859-3862.
8. Beck, J. M., R. L. Newbury, B. E. Palmer, W. L. Warnock, and P. K. Byrd. 1996. Role of CD8+ lymphocytes in host defense against Pneumocystis carinii in mice. J. Lab. Clin. Med. 128:477-487.
9. Beck, J. M., M. L. Warnock, J. L. Curtis, M. J. Sniezek, S. M. Arraj-Peffer, H. B. Kaltreider, and J. E. Shellito. 1991. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes. Am. J. Respir. Cell. Mol. Biol. 5:186-197.
10. Benfield, T. L., A. Kharazmi, C. G. Larsen, and J. D. Lundgren. 1997. Neutrophil chemotactic activity in bronchoalveolar lavage fluid of patients with AIDS-associated Pneumocystis carinii pneumonia. Scand. J. Infect. Dis. 29:367-371.
11. Benfield, T. L., B. Lundgren, S. J. Levine, G. Kronborg, J. H. Shelhamer, and J. D. Lundgren. 1997. The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytes. Infect. Immun. 65:4790-4794.
12. Benfield, T. L., J. K. Schattenkerk, B. Hofmann, B. N. Jensen, T. L. Nielsen, and J. D. Lundgren. 1994. Differential effect on serum neopterin and serum beta 2-microglobulin is induced by treatment in Pneumocystis carinii pneumonia. J. Infect. Dis. 169:1170-1173.
13. Benfield, T. L., R. van Steenwijk, T. L. Nielsen, J. R. Dichter, G. Y. Lipschik, B. N. Jensen, and J. Junge. 1995. Interleukin-8 and eicosanoid production in the lung during moderate to severe Pneumocystic carinii pneumonia in AIDS: a role of interleukin-8 in the pathogenesis of P. carinii pneumonia. Respir. Med. 89:285-290.
14. Benfield, T. L., J. Vestbo, J. Junge, T. L. Nielsen, A. B. Jensen, and J. D. Lundgren. 1995. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med. 151:1058-1062.
15. Blumenfeld, W., O. McCook, and J. M. Griffiss. 1992. Detection of antibodies to Pneumocystis carinii in bronchoalveolar lavage fluid by immunoreactivity to Pneumocystis carinii in the acquired immunodeficiency syndrome (AIDS). Mod. Pathol. 5:107-113.
16. Bonagura, V. R., S. Cunningham-Rundles, B. L. Edwards, N. T. Ilowite, J. T. Wedgewood, and D. J. Valcer. 1995. Common variable hypogammaglobulinemia, recurrent Pneumocystis carinii pneumonia on intravenous γ globulin therapy, and natural killer deficiency. Clin. Immunol. Immunopathol. 51:216-223.
17. Bonaguara, V. R., S. L. Cunningham-Rundles, and S. Schuval. 1992. Dysfunction of natural killer cells in human immunodeficiency virus-infected children with or without Pneumocystis carinii pneumonia. J. Pediatr. 121: 195-201.
18. Buhl, L., O. P. Settnes, and P. L. Andersen. 1993. Antibodies to Pneumocystis carinii in Danish blood donors and AIDS patients with and without Pneumocystis carinii pneumonia. APMIS 101:707-710.
19. Carr, A., C. Swanson, R. Penny, and D. A. Cooper. 1993. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J. Infect. Dis. 167:180-185.
20. Chatterton, J. M., A. W. Joss, H. Williams, and D. O. Ho-Yen. 1989. Pneumocystis carinii antibody testing. J. Clin. Pathol. 42:865-868.
21. Chen, W., E. A. Havell, L. L. Moldawer, R. A. McIntyre, R. A. Chizzonite, and A. G. Harmsen. 1992. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii infection. J. Exp. Med. 176:713-718.
22. Chen, W., J. W. Mills, and A. G. Harmsen. 1992. Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of bust inflammatory responses. Int. J. Exp. Pathol. 73:709-720.
23. Chen, W., E. A. Havell, and A. G. Harmsen. 1992. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279-1284.
24. Chen, W., E. A. Havell, F. Gigliotti, and A. G. Harmsen. 1992. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response. Infect. Immun. 61:97-102.
25. Clarke, J. R., I. K. Taylor, J. Fleming, J. D. Williamson, and D. M. Mitchell. 1993. Relation of HIV-I in bronchoalveolar lavage cells to abnormalities of lung function and to the presence of Pneumocystis pneumonia in HIV-I seropositive patients. Thorax 48:1222-1226.
26. De Benedetti, E., L. Nicod, G. Reber, C. Viffian, and P. deMorerhous. 1992. Procoagulant and fibrinolytic activities in bronchoalveolar fluid of HIV-positive and HIV-negative patients. Eur. Respir. J. 5:411-417.
27. Denis, M., and E. Ghadirian. 1994. Dysregulatin of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type I-infected subjects. AIDS Res. Hum. Retroviruses 10:1619-1627.
28. Duncan, R. A., C. F. Von Reyn, G. M. Alliegro, Z. Toosi, A. Sugar, and S. M. Levitz. 1993. Idiopathic CD4 T-lymphocytopenia: four patients with opportunistic infections and no evidence of HIV infection. N. Engl. J. Med. 328:393-398.
29. Elvin, K., A. Bjorkman, N. Heurlin, B. M. Eriksson, L. Barkholt, and E. Linder. 1994. Seroreactivity to Pneumocystis carinii in patients with AIDS versus other immunosuppressed patients. Scand. J. Infect. Dis. 26:33-40.
30. Esolen, L. M., M. B. Fasano, J. Flynn, A. Burton, and H. M. Lederman. 1992. Brief report. Pneumocystis carinii osteomyelitis in a patient with common variable immunodeficiency. N. Engl. J. Med. 326:909-1001.
31. Forte, M., G. Maartens, F. Campbell, C. Stubberfield, M. Shahmanesh, D. Kumararatne, and H. Gaston. 1992. T-lymphocyte responses to Pneumocystis carinii in healthy and HIV-positive individuals. J. Acquired Immune Defic. Syndr. 5:409-416.
32. Forte, M., M. Rahelu, C. Stubberfield, L. Tomkins, A. Pithie, and D. Kumararatne. 1991. In-vitro interaction of human macrophages with Pneumocystis carinii. Int. J. Exp. Pathol. 72:589-598.
33. Garbe, T. R., and J. R. Stringer. 1994. Molecular characterization of clustered variants of genes encoding major surface antigens of human Pneumocystis carinii. Infect. Immun. 62:3092-3101.
34. Garvy, B. A., R. A. B. Ezekowitz, and A. G. Harmsen. 1997. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect. Immun. 65:373-379.
35. Garvy, B. A., and A. G. Harmsen. 1996. Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults. Infect. Immun. 64:3987-3992.
36. Garvy, B. A., J. A. Wiley, F. Gigliotti, and A. G. Harmsen. 1997. Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect. Immun. 65:5052-5056.
37. Gigliotti, F. 1992. Host species-specific antigenic variation of a mannonsylated surface glycoprotein of Pneumocystis carinii. J. Infect. Dis. 165:329-336.
38. Gigliotti, F., B. A. Garvy, C. G. Haidaris, and A. G. Harmsen. 1998. Recognition of Pneumocystis carinii antigens by local antibody-secreting cells following resolution of P. carinii pneumonia in mice. J. Infect. Dis. 178: 235-242.
39. Gigliotti, F., and A. G. Harmsen. 1997. Pneumocystis carinii host origin defines the antibody specificity and protective response induced by immunization. J. Infect. Dis. 176:1322-1326.
40. Gigliotti, F., and W. T. Hughes. 1988. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J. Clin. Investig. 81:1666-1668.
41. Gigliotti, F., B. A. Garvy, and A. G. Harmsen. 1996. Antibody-mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pneumocystis carinii pneumonia. Infect. Immun. 64:1892-1899.
42. Gigliotti, F., J. A. Wiley, and A. G. Harmsen. 1998. Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia. Infect. Immun. 66:3179-3182.
43. Giron, J. A., S. Martinez, and P. D. Walzer. 1982. Should inpatients with Pneumocystis carinii be isolated? Lancet 2:46.
44. Guzman, J., Y. M. Wang, H. Teschler, K. Kienast, N. Brockmeyer, and U. Costabel. 1992. Phenotypic analysis of bronchoalveolar lavage lymphocytes from acquired immunodeficiency patients with and without Pneumocystis carinii pneumonia. Acta Cytol. 36:900-904.
45. Hagler, D. N., G. S. Deepe, C. L. Pogue, and P. D. Walzer. 1988. Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection. Clin. Exp. Immunol. 74:7-13.
46. Hanano, R., K. Reifenberg, and S. H. E. Kaufmann. 1996. Naturally acquired Pneumocystis carinii pneumonia in gene disruption mutant mice: roles of distinct T-cell populations in infection. Infect. Immun. 64:3201-3209.
47. Hanano, R., K. Reifenberg, and S. H. E. Kaufmann. 1998. Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii. Infect. Immun. 66:305-314.
48. Harmsen, A. G., W. Chen, and F. Gigliotti. 1995. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. Infect. Immun. 63:2391-2395.
49. Harmsen, A. G., and M. Stankiewicz. 1990. Requirement to CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172: 937-945.
50. Herrod, H. G., W. R. Valenski, D. R. Woods, and L. L. Pifer. 1981. The in vitro response of human lymphocytes to Pneumocystis carinii antigen. J. Immunol. 126:59-61.
51. Hoffman, A. G. D., M. G. Lawrence, and F. P. Ognibene. 1992. Reduction of pulmonary surfactant in patients with human immunodeficiency virus and Pneumocystis carinii pneumonia. Chest 102:1730-1736.
52. Hofmann, B., P. B. Nielsen, N. Odum, J. Gerstoft, P. Platz, L. P. Ryder, A. Poulsen, L. Mathiesen, E. Dickmeiss, B. Norrild, H. K. Andersen, B. F. Westergaard, C. M. Nielsen, W. Holten-Andersen, M. Mojon, J. O. Nielsen, and A. Svejaard. 1988. Humoral and cellular responses to Pneumocystis carinii, CMV, and herpes simplex in patients with AIDS and in controls. Scand. J. Infect. Dis. 20:389-394.
53. Huang, Z. B., and E. Eden. 1993. Effect of corticosteroids on IL1 beta and TNF alpha release by alveolar macrophages from patients with AIDS and Pneumocystis carinii pneumonia. Chest 104:751-755.
54. Hughes, W. T., H. Y. Kim, R. A. Price, and C. Miller. 1973. Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis. Curr. Ther. Res. 15:581-588.
55. Jacobs, J. L., D. M. Libby, R. A. Winters, D. M. Gelmont, E. D. Fried, B. J. Hartman, and J. P. Laurance. 1991. A cluster of Pneumocystis carinii pneumonia in adults without predisposing illnesses. N. Engl. J. Med. 324: 246-250.
56. Kandil, O., J. A. Fishman, H. Koziel, P. Pinkston, R. M. Rose, and H. G. Remold. 1994. Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect. Immun. 62:644-650.
57. Kolls, J. K., L. Dinghua, and C. Vazquez. 1997. Exacerbation of murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of TNF inhibitor. Am. J. Respir. Cell Mol. Biol. 16:112-118.
58. Kovacs, J. A., F. Powell, J. C. Edman, B. Lundgren, A. Martinez, B. Drew, and C. W. Angus. 1993. Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. J. Biol. Chem. 268:6034-6040.
59. Koziel, H., Q. Eichbaum, B. A. Kruskal, P. Pinkston, R. A. Rogers, M. Y. K. Armstrong, F. F. Richards, R. M. Rose, and R. A. B. Ezekowitz. 1998. Reduced binding and phagocytosis of pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J. Clin. Investig. 102:1332-1344.
60. Koziel, H., D. O'Riodan, and A. Warner. 1994. Alveolar macrophage interaction with Pneumocystis carinii. Immunology 60:417-436.
61. Krishnan, V. L., A. Meager, D. M. Mitchell, and A. J. Pinching. 1990. Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia. Clin. Exp. Immunol. 80:156-160.
62. Kumar, S. D., and B. P. Krieger. 1998. CD4 lymphocyte counts and mortality in AIDS patients requiring mechanical ventilator support due to Pneumocystis carinii pneumonia. Chest 113:430-433.
63. Laursen, A. L., B. N. Jensen, and P. L. Andersen. 1994. Local antibodies against Pneumocystis carinii in bronchoalveolar lavage fluid. Eur. Respir. J. 7:679-685.
64. Laursen, A. L., B. Moller, J. Rungby, C. M. Petersen, and P. L. Andersen. 1994. Pneumocystis carinii-induced activation of the respiratory burst in human monocytes and macrophages. Clin. Exp. Immunol. 98:196-202.
65. Laursen, A. L., J. Rungby, and P. L. Andersen. 1995. Decreased activation of the respiratory burst in neutrophils from AIDS patients with previous Pneumocystis carinii pneumonia. J. Infect. Dis. 172:497-505.
66. Leigh, T. R., M. J. Millett, B. Jameson, and J. V. Collins. 1993. Serum titres of Pneumocystis carinii antibody in health care workers caring for patients with AIDS. Thorax 48:619-621.
67. Lidman, C., M. Olsson, A. Bjorkman, and K. Elvin. 1997. No evidence of nosocomial Pneumocystis carinii infection via health care personnel. Scand. J. Infect. Dis. 29:63-64.
68. Limper, A. H. 1997. Tumor necrosis factor a-mediated host defense against Pneumocystis carinii. Am. J. Respir. Cell Mol. Biol. 16:110-111.
69. Limper, A. H., J. S. Hoyte, and J. E. Standing. 1997. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Investig. 99:2110-2117.
70. Limper, A. H., K. P. Offord, T. F. Smith, and W. J. Martin II. 1989. Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis. 140:1204-1209.
71. Linke, M. J., M. T. Cushion, and P. D. Walzer. 1989. Properties of the major rat and human Pneumocystis carinii antigens. Infect. Immun. 57: 1547-1555.
72. Linke, M. J., A. G. Smulian, J. R. Stringer, and P. D. Walzer. 1994. Characterization of multiple unique cDNAs encoding the major surface glycoprotein of rat-derived Pneumocystis carinii. Parasitol. Res. 80:478-486.
73. 72a. Linke, M. J., S. M. Sunkin, R. P. Andrews, J. R. Stringer, and P. D. Walzer. 1998. Expression, structure, and location of epitopes of the major surface glycoprotein of Pneumocystis carinii f. sp. carinii. Clin. Diagn. Lab. Immunol. 5:50-57.
74. Lipschik, G. Y., M. E. Doerfler, J. A. Kovacs, W. D. Travis, V. A. Andramis, M. G. Lawrence, J. R. Dichter, F. P. Ognibene, and J. H. Shelhamer. 1993. Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest 104:763-769.
75. Lipschik, G. Y., J. F. Treml, S. D. Moore, and M. F. Beers. 1998. Pneumocystis carinii glycoprotein A inhibits surfactant phospholipid secretion by rat alveolar type II cells. J. Infect. Dis. 177:182-187.
76. Lundgren, B., K. Elvin, L. P. Rothman, I. Ljungstrom, C. Lidman, and J. D. Lundgren. 1997. Transmission of Pneumocystis carinii from patients to hospital staff. Thorax 52:422-424.
77. Lundgren, B., J. A. Kovacs, L. Mathiesen, J. O. Nielsen, and J. D. Lundgren. 1993. IgM response to a human Pneumocystis carinii surface antigen in HIV-infected patients with pulmonary symptoms. Scand. J. Infect. Dis. 25:515-520.
78. Lundgren, B., G. Y. Lipchik, and J. A. Kovacs. 1991. Purification and characterization of a major human Pneumocystis carinii surface antigen. J. Clin. Investig. 87:163-170.
79. Lundgren, B., J. D. Lundgren, T. Nielsen, L. Mathiesen, J. O. Nielsen, and J. A. Kovacs. 1992. Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia. J. Infect. Dis. 165:1151-1155.
80. Mandujano, J. F., B. Nympha, B. D'Sousa, W. R. Summer, R. C. Beckerman, and J. E. Shellito. 1995. Granulocyte-macrophage colony stimulating factor and Pneumocystis carinii pneumonia in mice. Am. J. Respir. Care Med. 151:1233-1238.
81. Marcotte, H., D. Levesque, and K. Delanay. 1996. Pneumocystis carinii infection in transgenic B cell-deficient mice. J. Infect. Dis. 173:1034-1037.
82. Mason, G. R., C. H. Hashimoto, P. S. Dickman, L. F. Foutty, and C. J. Cobb. 1989. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am. Rev. Respir. Dis. 149:1336-1342.
83. Masur, H., and T. C. Jones. 1978. The interaction in vitro of Pneumocystis carinii with macrophage and L-cells. J. Exp. Med. 147:157-170.
84. McCormack, F. X., A. L. Festa, R. P. Andrews, M. Linke, and P. D. Walzer. 1997. The carbohydrate binding domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii. Biochemistry 36:8092-8099.
85. Mei, Q., R. E. Turner, V. Sorial, D. Klivington, C. W. Angus, and J. A. Kovacs. 1998. Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region. Infect. Immun. 66:4268-4273.
86. Meuwissen, J. H. E., I. A. Kagan, A. D. E. Leeuwenberg, P. J. A. Beckers, and M. Sieben. 1977. Parasitologic and serologic observations of infection with Pneumocystis in humans. J. Infect. Dis. 136:43-49.
87. Millar, A. B., R. F. Miller, N. M. Foley, A. Meager, S. J. Semple, and G. A. Rook. 1991. Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease. Am. J. Respir. Cell Mol. Biol, 5:144-148.
88. National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis carinii Pneumonia. 1990. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in acquired immunodeficiency syndrome. N. Engl. J. Med. 323:1500-1504.
89. Neese, L. W., J. E. Standing, E. J. Olson, M. Castro, and A. H. Limper. 1994. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-alpha in response to Pneumocystis carinii. J. Immunol. 152:4549-4556.
90. O'Riordan, D. M., J. E. Standing, K. Y. Kwon, D. Chang, E. C. Crouch, and A. H. Limper. 1995. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J. Clin. Investig. 95:2699-2710.
91. O'Riordan, D. M., J. E. Standing, and A. H. Limper. 1995. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect. Immun. 63:779-784.
92. Peglow, S. L., G. A. Smulian, M. J. Linke, J. Crisler, J. W. M. Phair, J. Gold, D. Armstrong, and P. D. Walzer. 1990. Serologic responses to specific Pneumocystis carinii antigens in health and disease. J. Infect. Dis. 161:296-306.
93. Perenboom, R. M., P. Beckers, J. W. Van Der Meer, A. C. Van Schijndel, W. J. Oyen, and F. H. Corstens. 1996. Pro-inflammatory cytokines in lung and blood during steroid-induced Pneumocystis carinii pneumonia in rats. J. Leukocyte Biol. 60:710-715.
94. Perenboom, R. M., R. W. Sauerwein, P. Beckers, A. C. van Schijndel, R. P. van Steenwijk, and J. C. Borleffs. 1997. Cytokine profiles in bronchoalveolar lavage fluid and blood in HIV-seropositive patients with Pneumocystis carinii pneumonia. Eur. J. Clin. Investig. 27:333-339.
95. Perenboom, R. M., A. C. van Schijndel, P. Beckers, R. Sauerwein, H. W. Van Hamersvelt, J. Festen, H. Gallati, and J. W. van der Meer. 1996. Cytokine profiles in bronchoalveolar lavage fluid and blood in HIV-seronegative patients with Pneumocystis carinii pneumonia. Eur. J. Clin. Investig. 26:159-166.
96. Phair, J., A. Munoz, R. Detels, R. Kaslow, C. Rinaldo, and D. Saah. 1990. The risk of Pneumocystis carinii pneumonia among men infected with immunodeficiency virus type 1. N. Engl. J. Med. 322:161-165.
97. Pifer, L. L., W. T. Hughes, S. Stago, and D. Woods. 1978. Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 61:35-41.
98. Pottratz, S. T., J. Paulsrud, J. S. Smith, and W. J. Martin II. 1991. Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J. Clin. Investig. 88:403-407.
99. Rankin, J. A., P. D. Walzer, J. M. Dwyer, C. E. Schraeder, R. Enriquez, and W. W. Merrill. 1983. Immunologic alterations in bronchoalveolar lavage fluid in the acquired immune deficiency syndrome (AIDS). Am. Rev. Respir. Dis. 128:189-194.
100. Rice, W. R., F. M. Singleton, M. J. Linke, and P. D. Walzer. 1993. Regulation of surfactant phosphatidycholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat. J. Clin. Investig. 92:2778-2882.
101. Roths, J. B., and C. L. Sidman. 1992. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ hut not CD8+ T cells into severe combined immunodeficiency mice. J. Clin. Investig. 90: 673-678.
102. Roths, J. B., and C. L. Sidman. 1993. Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice. Infect. Immun. 61:1641-1649.
103. Rudmann, D. G., A. M. Preston, M. W. Moore, and J. M. Beck. 1998. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of INF-γ and type 1 and 2 TNF receptor genes. J. Immun. 161: 360-366.
104. Ruebush, T. K., R. A. Weinstein, R. L. Baehner, D. Wolff, M. Barlett, F. Gonzales-Crussi, A. Sulzer, and M. G. Schultz. 1978. An outbreak of Pneumocystis pneumonia in children with acute lymphocytic leukemia. Am. J. Dis. Child. 132:143-148.
105. Russian, D. A., and J. A. Kovacs. 1995. Pneumocystis carinii in Africa: an emerging pathogen? Lancet 346:1242-1243.
106. Schofield, L. 1991. On the function of repetitive domains in protein antigens of Plasmodium and other eukaryotic parasites. Parasitol Today 7:99-105.
107. Sethi, K. K. 1990. Application of immunoblotting to detect soluble Pneumocystis carinii antigen(s) in bronchoalveolar lavage of patients with Pneumocyslis carinii and AIDS. J. Clin. Pathol. 43:584-586.
108. Shear, H. L., G. Valladares, and M. A. Narachi. 1990. Enhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-γ and reduced doses of trimethoprim/sulfamethoxazole. J. Acquired Immun Defic. Syndr. 3:943-948.
109. 2 in experimental Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis. 134:526-531.
110. Shellito, J. E., J. K. Kolls, R. Olariu, and J. M. Beck. 1996. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J. Infect. Dis. 173:432-439.
111. Shellito, J., V. V. Suzara, W. Blumenfeld, J. M. Beck, H. J. Steger, and T. H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of help T lymphocytes. J. Clin. Investig. 85:1686-1693.
112. Simonpoli, A. M., P. Rajagopalan-Levasseur, M. Brun-Pascaud, G. Bertrand, M. A. Pocidalo, and P. M. Girard. 1996. Influence of Pneumocystis carinii on nitrite production by rat alveolar macrophages. J. Eukaryot. Microbiol. 43:400-403.
113. Singer, C., D. Armstrong, P. P. Rosen, and D. Schottenfeld. 1975. Pneumocystis carinii pneumonia in a family. JAMA 193:685-686.
114. Smith, D. K., J. J. Neal, S. D. Holmberg, and Centers for Disease Control Idiopathic CD4 T-Lymphocytopenia Task Force. 1993. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. N. Engl. J. Med. 328:373-379.
115. Smulian, A. G., S. P. Keely, S. M. Sunkin, and J. R. Stringer. 1997. Genetic and antigenic variation in Pneumocystis carinii organisms: tools for examining the epidemiology and pathogenesis of infection. J. Lab. Clin. Med. 130:461-468.
116. Smulian, A. G., M. J. Linke, R. P. Baughman, M. Dohn, P. T. Frame, M. White, and P. D. Walzer. 1994. Analysis of Pneumocystis carinii antigens in bronchoalveolar lavage fluid in patients with pneumocystosis. AIDS 8:1555-1562.
117. Smulian, A. G., J. R. Stringer, M. J. Linke, and P. D. Walzer. 1992. Isolation and characterization of a recombinant immunoreactive antigen of Pneumocystis carinii. Infect. Immun. 60:907-915.
118. Smulian, A. G., D. Sullivan, M. J. Linke, N. Halsey, T. Quinn, A. P. MacPhail, J. Kreiss, R. T. Bryan, M. A. Hernandez, S. T. Hong, and P. D. Walzer. 1993. Geographic variation in the humoral response to Pneumocystis carinii. J. Infect. Dis. 167:1243-1247.
119. Smulian, A. G., S. A. Theus, N. Denko, P. D. Walzer, and J. R. Stringer. 1993. A 55 kDa antigen of Pneumocystis carinii: analysis of the cellular immune response and characterization of the gene. Mol. Microbiol. 7:745-753.
120. Smulian, A. G., and P. D. Walzer. 1994. Serological studies of Pneumocystis carinii infection, p. 141-151. In P. D. Walzer (ed.), Pneumocystis carinii pneumonia. Marcel Dekker, New York, N.Y.
121. Steinberg, R. I., J. A. Whitsett, W. M. Hull, and R. P. Baughman. 1995. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid. J. Lab. Clin. Med. 125:462-469.
122. Stringer, J. R., and P. D. Walzer. 1996. Molecular biology and epidemiology of Pneumocystis carinii infection in AIDS. AIDS 10:561-571.
123. Su, T. H., V. Natarajan, and D. L. Kachel. 1996. Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J. Lab. Clin. Med. 127:263-271.
124. Tamburrini, E., A. De Luca, G. Ventura, G. Maiuro, A. Siracusano, E. Ortona, and A. Antinori. 1991. Pneumocystis carinii stimulates in vitro production of tumor necrosis factor-alpha by human macrophages. Med. Microbiol. Immunol. 180:15-20.
125. Theus, S. A., R. P. Andrews, P. Stelle, and P. D. Walzer. 1995. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein confers protection in the rat. J. Clin. Investig. 95:2587-2593.
126. Theus, S. A., N. Sawhney, A. G. Smulian, and P. D. Walzer. 1998. Proliferation and cytokine responses of human T lymphocytes isolated from HIV patients to the major surface glycoprotein of Pneumocystis carinii. J. Infect. Dis. 177:238-241.
127. Theus, S. A., A. G. Smulian, P. Steele, M. J. Linke, and P. D. Walzer. 1998. Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine 16:1149-1157.
128. Theus, S. A., and P. D. Walzer. 1997. Adoptive transfer of specific lymphocyte populations sensitized to the major surface glycoprotein of Pneumocystis carinii decreases organism burden while increasing survival rate in the rat. J. Eukaryot. Microbiol. 44(Suppl.):23-24.
129. Vasquez, J., A. G. Smulian, M. J. Linke, and M. T. Cushion. 1996. Antigenic differences associated with genetically distinct Pneumocystis carinii from rats. Infect. Immun. 64:290-297.
130. Villard, J., F. Dayer-Pastore, J. Harnacher, J. D. Aubert, S. Schlegel-Haueter, and L. P. Nicod. 1995. GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 152:1549-1554.
131. Wakefield, A. E., T. J. Stewart, E. R. Moxon, K. Marsh, and J. N. Hopkins. 1990. Infection with Pneumocystis carinii is prevalent in healthy Gambian children. Trans. R. Soc. Trop. Med. Hyg. 84:800-802.
132. Walzer, P. D. 1995. Pneumocystis carinii, p. 2475-2487. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious disease. Churchill Livingstone, Inc., New York, N.Y.
133. Walzer, P. D. 1997. Editorial response: Pneumocystis carinii pneumonia in patients without human immunodeficiency virus infection. Clin. Infect. Dis. 25:219-220.
134. Walzer, P. D., and M. J. Linke. 1987. A comparison of the antigenic characteristics of rat and human Pneumocystis carinii by immunoblotting. J. Immunol. 138:2257-2265.
135. Walzer, P. D., J. Runck, P. Steele, M. White, M. J. Linke, and C. L. Sidman. 1997. Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs. Antimicrob. Agents Chemother. 41:251-258.
136. Walzer, P. D., D. Stanforth, M. J. Linke, and M. T. Cushion. 1987. Pneumocystis carinii: immunoblotting and immunofluorescent analysis of serum antibodies during experimental rat infection and recovery. Exp. Parasitol. 63:319-328.
137. Warschkau, H., H. Yu, and A. F. Kiderlen. 1998. Activation and suppression of natural cellular immune functions by Pneumocystis carinii. Immunobiology 198:343-360.
138. Wiley, J. A., and A. G. Harmsen. 1995. CD 40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155: 3525-3529.
139. Wright, T. W., C. J. Johnston, A. G. Harmsen, and J. N. Finkelstein. 1997. Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice. Am. J. Respir. Cell Mol. Biol. 17:491-500.